Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New CDK inhibitors in BMS development pipeline

Sep. 25, 2003

New antiangiogenic agents and their use patented by EntreMed

Sep. 25, 2003

Takeda presents new GnRH antagonists for cancer, prostatic hypertrophy, etc.

Sep. 25, 2003

FDA grants satraplatin fast track designation

Sep. 25, 2003

Corixa initiates phase I clinical study for NSCLC vaccine

Sep. 23, 2003

Ligand completes enrollment in pivotal study of Targretin in NSCLC

Sep. 23, 2003

Brand name chosen for ABI-007

Sep. 23, 2003

Six-month priority review granted for Eloxatin sNDA

Sep. 22, 2003

Dow and Sunol collaborate on plant-based production of antibody for cancer

Sep. 22, 2003

Fast track designation awarded to Advexin for head & neck cancer

Sep. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...